SciELO - Scientific Electronic Library Online

 
vol.62 issue2Características epidemiológicas, endoscópicas e histológicas de pacientes con enfermedad inflamatoria intestinalPrevalencia de enfermedad por reflujo gastroesofágico en población adulta del área metropolitana de Caracas Venezuela author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Gen

Print version ISSN 0016-3503On-line version ISSN 2477-975X

Abstract

LOPEZ, Carmen Esther  and  PESTANA, Elena. Efectividad del interferon pegilado y ribavirina en la respuesta viral sostenida en niños con Hepatitis C. Gen [online]. 2008, vol.62, n.2, pp.106-108. ISSN 0016-3503.

The objective of this study is to evaluate the efficacy of combination therapy of Interferon and Pegylated Ribavirin in pediatric patients. Materials and methods: 18 patients with chronic hepatitis C, showed ARNVHC positive quantitative viremia, genotype; all liver biopsies were performed prior to treatment. treatment with pegylated interferon and ribavirin was given for 1 year. At 6 months after the completion of treatment ARNVHC was conducted. Results: Ages of the patients were between 3 and 13 years, 55.56% female. Vertical transmission was 22.23%. 3 / 18 suspended treatment. There was a statistically significant reduction of viremia in patients without sustained viral response. 40% had no fibrosis and 40% had mild fibrosis in the liver biopsy. 14/15 were genotype 1; 1 / 15 genotype 2.In 11/15 a RNA was performed at 6 months during treatment, culminating 6 months after treatment, both answers were compared with no significant differences. 60% sustained viral response. Conclusion: Although the progression of hepatitis C in children is slow, treatment with pegylated interferon and ribavirin is useful at this age because children have favorable prognostic factors to obtain a sustained viral response.

Keywords : Hepatitis C in children; treatment; pegylated interferon; ribavirin.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License